Establishment Labs Holdings Past Earnings Performance
Past criteria checks 0/6
Establishment Labs Holdings's earnings have been declining at an average annual rate of -20.5%, while the Medical Equipment industry saw earnings growing at 11.4% annually. Revenues have been growing at an average rate of 17.5% per year.
Key information
-20.5%
Earnings growth rate
-15.5%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 17.5% |
| Return on equity | -184.8% |
| Net Margin | -55.0% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Earnings Release: Here's Why Analysts Cut Their Establishment Labs Holdings Inc. (NASDAQ:ESTA) Price Target To US$59.86
Aug 11
Shareholders Should Be Pleased With Establishment Labs Holdings Inc.'s (NASDAQ:ESTA) Price
Jul 23Establishment Labs: Catalysts Supporting A Perky Outlook
Jan 28Is Establishment Labs Holdings (NASDAQ:ESTA) A Risky Investment?
Dec 08Is Establishment Labs Holdings (NASDAQ:ESTA) Using Too Much Debt?
Aug 10Shareholders Should Be Pleased With Establishment Labs Holdings Inc.'s (NASDAQ:ESTA) Price
Apr 17Establishment Labs Holdings (NASDAQ:ESTA) Is Carrying A Fair Bit Of Debt
Dec 14Establishment Labs drops 18% after new short report from Hindenburg Research
Oct 19Establishment Labs: Flat Earnings, Return On Investment Keep Buyers At Bay
Sep 24Establishment Labs Holdings (NASDAQ:ESTA) Is Carrying A Fair Bit Of Debt
Sep 04Establishment Labs started at buy at B Riley on breast implants
Aug 24Health Check: How Prudently Does Establishment Labs Holdings (NASDAQ:ESTA) Use Debt?
Feb 23Is Establishment Labs Holdings (NASDAQ:ESTA) Using Debt Sensibly?
Sep 25Revenue & Expenses Breakdown
How Establishment Labs Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 151 | -83 | 139 | 23 |
| 31 Mar 24 | 156 | -83 | 143 | 24 |
| 31 Dec 23 | 165 | -79 | 146 | 26 |
| 30 Sep 23 | 177 | -72 | 144 | 27 |
| 30 Jun 23 | 177 | -61 | 135 | 25 |
| 31 Mar 23 | 170 | -81 | 131 | 23 |
| 31 Dec 22 | 162 | -75 | 126 | 20 |
| 30 Sep 22 | 153 | -76 | 119 | 20 |
| 30 Jun 22 | 144 | -72 | 112 | 18 |
| 31 Mar 22 | 135 | -40 | 101 | 18 |
| 31 Dec 21 | 127 | -41 | 92 | 18 |
| 30 Sep 21 | 118 | -33 | 83 | 17 |
| 30 Jun 21 | 112 | -22 | 73 | 16 |
| 31 Mar 21 | 91 | -27 | 66 | 14 |
| 31 Dec 20 | 85 | -38 | 67 | 14 |
| 30 Sep 20 | 82 | -38 | 66 | 13 |
| 30 Jun 20 | 82 | -47 | 70 | 14 |
| 31 Mar 20 | 93 | -45 | 74 | 16 |
| 31 Dec 19 | 90 | -38 | 71 | 15 |
| 30 Sep 19 | 82 | -43 | 69 | 15 |
| 30 Jun 19 | 75 | -29 | 62 | 14 |
| 31 Mar 19 | 67 | -25 | 55 | 14 |
| 31 Dec 18 | 61 | -21 | 47 | 13 |
| 30 Sep 18 | 57 | -18 | 41 | 11 |
| 30 Jun 18 | 48 | -30 | 36 | 10 |
| 31 Mar 18 | 43 | -36 | 34 | 8 |
| 31 Dec 17 | 35 | -35 | 31 | 7 |
| 31 Dec 16 | 20 | -22 | 23 | 3 |
Quality Earnings: ESTA is currently unprofitable.
Growing Profit Margin: ESTA is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ESTA is unprofitable, and losses have increased over the past 5 years at a rate of 20.5% per year.
Accelerating Growth: Unable to compare ESTA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ESTA is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (7.2%).
Return on Equity
High ROE: ESTA has a negative Return on Equity (-184.81%), as it is currently unprofitable.